|
CH587021A5
(https=)
|
1974-06-07 |
1977-04-29 |
Nestle Sa |
|
|
EP0173552B1
(en)
|
1984-08-24 |
1991-10-09 |
The Upjohn Company |
Recombinant dna compounds and the expression of polypeptides such as tpa
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US5651991A
(en)
|
1987-10-28 |
1997-07-29 |
Nippon Shinyaku Co. Ltd. |
Drug carriers
|
|
US5549910A
(en)
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
|
US5252334A
(en)
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
|
JP3218637B2
(ja)
|
1990-07-26 |
2001-10-15 |
大正製薬株式会社 |
安定なリポソーム水懸濁液
|
|
JP2958076B2
(ja)
|
1990-08-27 |
1999-10-06 |
株式会社ビタミン研究所 |
遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
|
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
|
JPH07285863A
(ja)
|
1994-02-25 |
1995-10-31 |
Takeda Chem Ind Ltd |
注射剤組成物およびその製造方法
|
|
ES2078190B1
(es)
|
1994-05-20 |
1996-08-01 |
Cusi Lab |
Procedimiento para el recubrimiento de goticulas o particulas de tamaño nanometrico.
|
|
US5741516A
(en)
|
1994-06-20 |
1998-04-21 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US5697899A
(en)
|
1995-02-07 |
1997-12-16 |
Gensia |
Feedback controlled drug delivery system
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
US5738868A
(en)
|
1995-07-18 |
1998-04-14 |
Lipogenics Ltd. |
Liposome compositions and kits therefor
|
|
US5656016A
(en)
|
1996-03-18 |
1997-08-12 |
Abbott Laboratories |
Sonophoretic drug delivery system
|
|
US5797898A
(en)
|
1996-07-02 |
1998-08-25 |
Massachusetts Institute Of Technology |
Microchip drug delivery devices
|
|
US5783208A
(en)
|
1996-07-19 |
1998-07-21 |
Theratech, Inc. |
Transdermal drug delivery matrix for coadministering estradiol and another steroid
|
|
US5779708A
(en)
|
1996-08-15 |
1998-07-14 |
Cyberdent, Inc. |
Intraosseous drug delivery device and method
|
|
AU722624B2
(en)
|
1996-09-06 |
2000-08-10 |
Trustees Of The University Of Pennsylvania, The |
An inducible method for production of recombinant adeno-associated viruses utilizing T7 polymerase
|
|
US6007856A
(en)
|
1997-08-08 |
1999-12-28 |
The Procter & Gamble Company |
Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid
|
|
ATE372377T1
(de)
|
1998-03-30 |
2007-09-15 |
Mibelle Ag Cosmetics |
Verwendung von nanoemulsionen zur bestimmung der biokompatibilität von lipophilen stoffen im zellkultur-test und dafür geeignete nanoemulsionen
|
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
US8026096B1
(en)
|
1998-10-08 |
2011-09-27 |
Protein Sciences Corporation |
In vivo active erythropoietin produced in insect cells
|
|
ATE226449T1
(de)
|
1998-12-03 |
2002-11-15 |
Avigen Inc |
Hilfsstoffe zur verwendung in adeno-assoziiertes virus enthaltenden pharmazeutischen zubereitungen und damit hergestellte pharmazeutische zubereitungen
|
|
FR2787728B1
(fr)
|
1998-12-23 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras d'acide phosphorique, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
US6258595B1
(en)
|
1999-03-18 |
2001-07-10 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
US6627617B1
(en)
|
1999-10-01 |
2003-09-30 |
University Of North Carolina At Chapel Hill |
Temperature-sensitive regulation of viral vector production
|
|
US7208315B2
(en)
|
2000-01-05 |
2007-04-24 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for efficient AAV vector production
|
|
WO2001066782A1
(en)
|
2000-03-03 |
2001-09-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Adeno-associated viral compositions and methods
|
|
MXPA02009275A
(es)
|
2000-03-23 |
2004-09-06 |
Collaborative Technologies Inc |
Metodo para preparar dispersiones de alta presion/alto esfuerzo cortante que contienen ingredientes fisiologicamente activos.
|
|
WO2001070972A2
(en)
|
2000-03-24 |
2001-09-27 |
Yasunaga, Shin'ichiro |
Multiple human and mouse otoferlin isoforms
|
|
RS49646B
(sr)
|
2000-07-04 |
2007-09-21 |
Slobodan Arsenijević |
Instrument za ubrizgavanje fluida i dilataciona sonda za uvođenje u telesne šupljine
|
|
FR2811561B1
(fr)
|
2000-07-13 |
2003-03-21 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et/ou un precurseur ou derive chimique ou biologique de celle-ci, et un inhibiteur de metalloproteinase
|
|
US6593123B1
(en)
|
2000-08-07 |
2003-07-15 |
Avigen, Inc. |
Large-scale recombinant adeno-associated virus (rAAV) production and purification
|
|
US6329181B1
(en)
|
2000-08-07 |
2001-12-11 |
Neurologix, Inc. |
Helper functions for recombinant vector production
|
|
US20040048836A1
(en)
|
2001-03-23 |
2004-03-11 |
Wilmott James M |
Method for preparing high pressure/ high shear dispersions containing physiologically active ingredients
|
|
EP1377255A4
(en)
|
2001-03-30 |
2008-11-19 |
Color Access Inc |
NEW NANOEMULSIONS
|
|
KR100463167B1
(ko)
|
2001-04-13 |
2004-12-23 |
주식회사 태평양 |
고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
|
|
WO2004030608A2
(en)
|
2001-06-05 |
2004-04-15 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
JP2004538005A
(ja)
|
2001-08-08 |
2004-12-24 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
シアル酸に結合するタンパク質を有するウイルスベクターの精製法
|
|
US20040115159A1
(en)
|
2002-03-29 |
2004-06-17 |
Tadlock Charles C |
Novel nanoemulsions
|
|
AU2003221733A1
(en)
*
|
2002-04-17 |
2003-11-03 |
University Of Florida Research Foundation, Inc. |
Improved raav vectors
|
|
US7071172B2
(en)
|
2002-04-30 |
2006-07-04 |
The University Of North Carolina At Chapel Hill |
Secretion signal vectors
|
|
US20060127358A1
(en)
*
|
2002-05-01 |
2006-06-15 |
Nicholas Muzyczka |
Raav expression systems and methods for enhancing transduction of mammalian neural cells
|
|
US7419817B2
(en)
|
2002-05-17 |
2008-09-02 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. |
Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
|
|
JP4824311B2
(ja)
|
2002-09-12 |
2011-11-30 |
スリーエム イノベイティブ プロパティズ カンパニー |
低温特性および耐溶剤性を有するフルオロエラストマー
|
|
US7329688B2
(en)
|
2002-12-17 |
2008-02-12 |
Soft Gel Technologies, Inc. |
Natural vitamin E compositions with superior antioxidant potency
|
|
DE602004030327D1
(de)
|
2003-05-21 |
2011-01-13 |
Genzyme Corp |
Verfahren zur herstellung von präparationen rekombinanter aav-virionen, die weitgehend frei von leeren capsiden sind
|
|
AU2004273779B2
(en)
|
2003-06-04 |
2009-10-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
|
|
WO2005013938A1
(ja)
|
2003-08-06 |
2005-02-17 |
Eisai Co., Ltd. |
薬物超微粒子の製造法及び製造装置
|
|
US7387614B2
(en)
|
2003-08-26 |
2008-06-17 |
University Of Maryland, Baltimore |
Drug delivery to the inner ear and methods of using same
|
|
EP1510206A1
(en)
|
2003-08-29 |
2005-03-02 |
Novagali Pharma SA |
Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
|
|
BRPI0415858A
(pt)
|
2003-10-29 |
2007-01-09 |
Sonus Pharma Inc |
compostos de medicamentos terapêuticos modificados por tocoferol
|
|
CA2553676A1
(en)
|
2004-01-28 |
2005-08-11 |
Research Development Foundation |
Human soluble neuropilin-1 primary polyadenylation signal and uses thereof
|
|
EP1718163A1
(en)
|
2004-02-23 |
2006-11-08 |
The Texas A&M University System |
Antioxidant compositions and methods of use thereof
|
|
US7419497B2
(en)
|
2004-04-21 |
2008-09-02 |
Acclarent, Inc. |
Methods for treating ethmoid disease
|
|
EP1751275B1
(en)
|
2004-06-01 |
2017-08-16 |
Avigen, Inc. |
Compositions and methods to prevent aav vector aggregation
|
|
US20050281786A1
(en)
|
2004-06-18 |
2005-12-22 |
David Poulsen |
AAV mediated gene delivery to cochlear cells
|
|
US20060040354A1
(en)
|
2004-07-20 |
2006-02-23 |
O'keefe Theresa L |
Novel polyadenylation signal for use in expression vectors
|
|
US20070055199A1
(en)
|
2005-08-10 |
2007-03-08 |
Gilbert Scott J |
Drug delivery device for buccal and aural applications and other areas of the body difficult to access
|
|
EP2311967B1
(en)
|
2005-10-20 |
2017-09-20 |
UniQure IP B.V. |
Improved AAV vectors produced in insect cells
|
|
EP2018421B1
(en)
|
2006-04-28 |
2012-12-19 |
The Trustees of the University of Pennsylvania |
Scalable production method for aav
|
|
US7851196B2
(en)
|
2006-05-01 |
2010-12-14 |
The Regents Of The University Of California |
Methods for purifying adeno-associated virus particles
|
|
KR101589259B1
(ko)
|
2006-06-21 |
2016-02-01 |
유니큐어 아이피 비.브이. |
곤충세포 내 ａａｖ의 생산에 유용한 ａａｖ-ｒｅｐ78의 번역을 위한 변형된 개시 코돈을 갖는 벡터
|
|
US20080065002A1
(en)
|
2006-09-07 |
2008-03-13 |
Neurosystec Corporation |
Catheter for Localized Drug Delivery and/or Electrical Stimulation
|
|
SI3093345T1
(sl)
|
2007-07-26 |
2019-08-30 |
Uniqure Ip B.V. |
Bakulovirusni vektorji, ki vsebujejo ponavljajoča kodirna zaporedja z različnimi kodonskimi preferencami
|
|
US20090042825A1
(en)
|
2007-08-06 |
2009-02-12 |
Majed Matar |
Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer
|
|
US8236557B2
(en)
|
2008-05-28 |
2012-08-07 |
University Of Missouri-Columbia |
Hybrid-AAV vectors to deliver large gene expression cassette
|
|
PL2356241T3
(pl)
|
2008-11-28 |
2018-12-31 |
Anton Bauer |
Wektor sztucznego chromosomu
|
|
HUE028341T2
(en)
|
2009-06-16 |
2016-12-28 |
Genzyme Corp |
Improved methods for purification of recombinant aav vectors
|
|
JP5697123B2
(ja)
|
2009-07-27 |
2015-04-08 |
国立大学法人 千葉大学 |
酸性化ポリエチレンイミンを用いる細胞への核酸導入方法
|
|
WO2011075838A1
(en)
|
2009-12-21 |
2011-06-30 |
Audigen Inc. |
Method of treating or preventing hearing loss
|
|
DK2529020T3
(en)
|
2010-01-28 |
2018-08-06 |
Childrens Hospital Philadelphia |
SCALABLE PREPARATION PLATF FOR CLEANING VIRAL VECTORS AND CLEANED VIRAL VECTORS FOR USE IN GENTHERAPY
|
|
WO2011112089A2
(en)
|
2010-03-11 |
2011-09-15 |
Amsterdam Molecular Therapeutics (Amt) Ip B.V. |
Mutated rep encoding sequences for use in aav production
|
|
EP2392208B1
(en)
|
2010-06-07 |
2016-05-04 |
Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use
|
|
EP2605761A1
(fr)
|
2010-08-19 |
2013-06-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Dispositif implantable dans l'os temporal pour administrer un produit et prothèse auditive pourvue d'un tel dispositif.
|
|
EP2500434A1
(en)
|
2011-03-12 |
2012-09-19 |
Association Institut de Myologie |
Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
|
|
WO2012168307A2
(en)
|
2011-06-07 |
2012-12-13 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Improved recombination efficiency by inhibition of nhej dna repair
|
|
US8852165B2
(en)
|
2011-06-16 |
2014-10-07 |
II Edward G. Mackay |
Endoluminal drug delivery devices and methods
|
|
US9441206B2
(en)
|
2011-10-28 |
2016-09-13 |
The University Of North Carolina At Chapel Hill |
Cell line for production of adeno-associated virus
|
|
WO2013075008A1
(en)
|
2011-11-16 |
2013-05-23 |
University Of Florida Research Foundation Inc. |
Aav dual vector systems for gene therapy
|
|
AU2013221212B2
(en)
|
2012-02-17 |
2018-08-09 |
The Children's Hospital Of Philadelphia |
AAV vector compositions and methods for gene transfer to cells, organs and tissues
|
|
US11332719B2
(en)
|
2013-03-15 |
2022-05-17 |
The Broad Institute, Inc. |
Recombinant virus and preparations thereof
|
|
CA2909733C
(en)
|
2013-04-18 |
2023-10-17 |
Fondazione Telethon |
Effective delivery of large genes by dual aav vectors
|
|
EP3039129B1
(en)
|
2013-08-30 |
2018-06-27 |
Amgen Inc. |
High titer recombinant aav vector production in adherent and suspension cells
|
|
HUE052676T2
(hu)
|
2013-10-11 |
2021-05-28 |
Massachusetts Eye & Ear Infirmary |
Eljárások õsi vírusszekvenciák elõrejelzésére és alkalmazásaik
|
|
WO2015137802A1
(en)
|
2014-03-10 |
2015-09-17 |
Uniqure Ip B.V. |
Further improved aav vectors produced in insect cells
|
|
US10526583B2
(en)
|
2014-07-02 |
2020-01-07 |
University Of Florida Research Foundation, Incorporated |
Compositions and methods for purifying recombinant adeno-associated virus
|
|
SG11201704919SA
(en)
|
2015-01-13 |
2017-07-28 |
Alfa Wassermann Inc |
Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav)
|
|
EP3054006A1
(en)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
|
|
US10751385B2
(en)
|
2015-02-20 |
2020-08-25 |
Institut Pasteur |
Prevention and/or treatment of hearing loss or impairment
|
|
RS63416B1
(sr)
|
2015-03-03 |
2022-08-31 |
Fond Telethon |
Sistem višestrukih vektora i njegove primene
|
|
PL3265568T3
(pl)
|
2015-03-06 |
2020-11-30 |
Massachusetts Eye & Ear Infirmary |
Terapie augmentacji genów w przypadku wrodzonego zwyrodnienia siatkówki spowodowanego mutacjami genu prpf31
|
|
CA2994160C
(en)
|
2015-07-30 |
2021-08-10 |
Massachusetts Eye And Ear Infirmary |
Ancestral virus sequences and uses thereof
|
|
AU2016362317B2
(en)
|
2015-12-01 |
2023-03-16 |
Spark Therapeutics, Inc. |
Scalable methods for producing recombinant Adeno-Associated Viral (AAV) vector in serum-free suspension cell culture system suitable for clinical use
|
|
SG11201804814YA
(en)
|
2015-12-11 |
2018-07-30 |
Massachusetts Eye & Ear Infirmary |
Materials and methods for delivering nucleic acids to cochlear and vestibular cells
|
|
WO2017108931A1
(en)
|
2015-12-22 |
2017-06-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Improved hybrid dual recombinant aav vector systems for gene therapy
|
|
CN109219439B
(zh)
|
2016-01-29 |
2022-09-20 |
马萨诸塞眼科耳科诊所 |
内耳支持细胞的扩增和分化及其使用方法
|
|
WO2017136764A1
(en)
|
2016-02-05 |
2017-08-10 |
The General Hospital Corporation |
Hybrid system for efficient gene delivery to cells of the inner ear
|
|
JP2019522539A
(ja)
|
2016-06-22 |
2019-08-15 |
ザ チャールズ スターク ドレイパー ラボラトリー， インク．Ｔｈｅ Ｃｈａｒｌｅｓ Ｓｔａｒｋ Ｄｒａｐｅｒ Ｌａｂｏｒａｔｏｒｙ， Ｉｎｃ． |
経正円窓膜注入による内耳薬物送達用のシステム
|
|
GB201612248D0
(en)
|
2016-07-14 |
2016-08-31 |
Puridify Ltd |
New process
|
|
KR102695908B1
(ko)
|
2016-07-21 |
2024-08-14 |
스파크 테라퓨틱스, 인코포레이티드 |
재조합 아데노-관련 바이러스(rAAV) 벡터를 고수율로 생산하기 위한 확장 가능한 고회수 방법 및 이에 의해 생산된 재조합 아데노-관련 바이러스(rAAV) 벡터
|
|
PE20190401A1
(es)
|
2016-07-26 |
2019-03-13 |
Biomarin Pharm Inc |
Novedosas proteinas de la capside del virus adenoasociado
|
|
JP2019530737A
(ja)
|
2016-08-23 |
2019-10-24 |
アコーオス インコーポレイテッド |
ヒト対象において非加齢性聴力障害を治療するための組成物および方法
|
|
WO2018080895A1
(en)
*
|
2016-10-24 |
2018-05-03 |
Cummins Inc. |
Waste heat recovery vehicle cooling optimization
|
|
KR102482744B1
(ko)
|
2016-11-04 |
2022-12-30 |
다케다 야쿠힌 고교 가부시키가이샤 |
아데노-연관 바이러스 정제 방법
|
|
US10626376B2
(en)
|
2016-11-14 |
2020-04-21 |
St. Jude Children's Research Hospital |
Method for isolating and purifying adeno-associated virus particles using salt
|
|
FI3568483T3
(fi)
|
2017-01-10 |
2025-11-21 |
Childrens Medical Res Institute |
Polynukleotideja ja vektoreita siirtogeenien ilmentämiseen
|
|
WO2018145111A1
(en)
|
2017-02-06 |
2018-08-09 |
Children's Medical Center Corporation |
Materials and methods for delivering nucleic acids to cochlear and vestibular cells
|
|
AU2018261769B2
(en)
|
2017-05-05 |
2024-03-14 |
The Regents Of The University Of California |
Compositions and methods for expressing Otoferlin
|
|
EP3618839A4
(en)
|
2017-05-05 |
2021-06-09 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
JP2020518266A
(ja)
|
2017-05-05 |
2020-06-25 |
ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
調節性ポリヌクレオチド
|
|
JP2020518259A
(ja)
|
2017-05-05 |
2020-06-25 |
ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
ハンチントン病治療組成物および方法
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
JP7221275B2
(ja)
|
2017-08-03 |
2023-02-13 |
ボイジャー セラピューティクス インコーポレイテッド |
Ａａｖを送達するための組成物および方法
|
|
WO2019060649A1
(en)
|
2017-09-22 |
2019-03-28 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
|
|
WO2019084145A1
(en)
|
2017-10-25 |
2019-05-02 |
The Charles Stark Draper Laboratory Inc. |
APPARATUS AND METHOD FOR DRUG DELIVERY ACROSS THE ROUND WINDOW MEMBRANE
|
|
KR20200122320A
(ko)
|
2018-01-16 |
2020-10-27 |
씨엘에스 테라퓨틱스 리미티드 |
데옥시리보뉴클레아제 (dnase) 활성을 갖는 효소의 간 발현에 의한 질환의 치료
|
|
CN112020359A
(zh)
|
2018-02-09 |
2020-12-01 |
分贝治疗公司 |
含有抗铂化学保护剂的高渗药物组合物
|
|
DE102018103924A1
(de)
|
2018-02-21 |
2019-08-22 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
Gentherapeutische Behandlung von Schwerhörigkeit
|
|
IL325122A
(en)
|
2018-02-22 |
2026-02-01 |
Akouos Inc |
Compositions and methods for treating non-age-related hearing impairment in humans
|
|
JP7430652B2
(ja)
|
2018-03-05 |
2024-02-13 |
ザ チルドレンズ メディカル センター コーポレーション |
蝸牛および前庭細胞に核酸を送達するための組成物および方法
|
|
US11660353B2
(en)
|
2018-04-27 |
2023-05-30 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
CN119410636A
(zh)
|
2018-04-27 |
2025-02-11 |
分贝治疗公司 |
肌球蛋白15启动子及其用途
|
|
SG11202011296VA
(en)
|
2018-05-15 |
2020-12-30 |
Voyager Therapeutics Inc |
Compositions and methods for the treatment of parkinson's disease
|
|
TW202015742A
(zh)
|
2018-05-15 |
2020-05-01 |
美商航海家醫療公司 |
投遞腺相關病毒（ａａｖ）之組成物和方法
|
|
AU2019299964A1
(en)
|
2018-07-11 |
2021-01-21 |
Takeda Pharmaceutical Company Limited |
AAV compositions
|
|
AU2019310459A1
(en)
|
2018-07-24 |
2021-02-18 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
|
WO2020069320A1
(en)
|
2018-09-27 |
2020-04-02 |
Akouos, Inc. |
A method for treating an auditory neuropathy spectrum disorder
|
|
CA3115810A1
(en)
|
2018-10-11 |
2020-04-16 |
Decibel Therapeutics, Inc. |
Aav1 vectors and uses thereof for treatment of otic indications
|
|
US12188041B2
(en)
|
2018-11-01 |
2025-01-07 |
University Of Florida Research Foundation, Incorporated |
Codon optimized otoferlin AAV dual vector gene therapy
|
|
CN118497276A
(zh)
|
2018-11-07 |
2024-08-16 |
阿库斯股份有限公司 |
腺相关病毒载体用于在内耳中的毛细胞和支持细胞中校正基因缺陷/表达蛋白质的用途
|
|
WO2020148458A1
(en)
|
2019-01-18 |
2020-07-23 |
Institut Pasteur |
Aav-mediated gene therapy restoring the otoferlin gene
|
|
CN110437317B
(zh)
|
2019-01-30 |
2023-05-02 |
上海科技大学 |
具有变异衣壳蛋白的腺相关病毒及其用途
|
|
EP3921032A4
(en)
|
2019-02-08 |
2022-11-30 |
Decibel Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
|
|
AU2020218547A1
(en)
|
2019-02-08 |
2021-08-26 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
|
EP3967706A4
(en)
|
2019-05-08 |
2022-12-28 |
Center For Excellence In Brain Science And Intelligence Technology, Chinese Academy Of Sciences |
AAV MUTANT FOR EFFICIENT INFECTION OF SUPPORT CELLS
|
|
CA3153133A1
(en)
|
2019-09-30 |
2021-04-08 |
Chris Bartolome |
Adeno-associated virus (aav) systems for treatment of genetic hearing loss
|
|
EP4045092A1
(en)
|
2019-10-18 |
2022-08-24 |
Research Institute at Nationwide Children's Hospital |
Gene therapy targeting cochlear cells
|
|
CA3159549A1
(en)
|
2019-10-30 |
2021-05-06 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
EP4058571A1
(en)
|
2019-11-11 |
2022-09-21 |
Salk Institute for Biological Studies |
Compositions and methods for high-efficiency recombination of rna molecules
|
|
WO2021150850A1
(en)
|
2020-01-24 |
2021-07-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Svcs. |
Adeno-associated viruses and their uses for inner ear therapy
|
|
CA3168903A1
(en)
|
2020-02-07 |
2021-08-12 |
University Of Rochester |
Ribozyme-mediated rna assembly and expression
|
|
JP7846626B2
(ja)
|
2020-02-07 |
2026-04-15 |
ザ チルドレンズ メディカル センター コーポレーション |
大型遺伝子ベクターならびにその送達および使用の方法
|
|
JP7807380B2
(ja)
|
2020-02-21 |
2026-01-27 |
アコーオス インコーポレイテッド |
ヒト対象において非加齢関連聴力障害を処置するための組成物および方法
|
|
WO2021183825A1
(en)
|
2020-03-12 |
2021-09-16 |
California Institute Of Technology |
Adeno-associated viral capsids with expanded sizes
|
|
CN111349148A
(zh)
|
2020-03-13 |
2020-06-30 |
辉大(上海)生物科技有限公司 |
一种腺相关病毒载体及其用途
|
|
EP3885440A1
(en)
|
2020-03-26 |
2021-09-29 |
Splicebio, S.L. |
Split inteins and their uses
|
|
US20240016955A1
(en)
|
2020-09-14 |
2024-01-18 |
President And Fellows Of Harvard College |
Dual-aav vector delivery of pcdh15 and uses thereof
|
|
AU2021376225A1
(en)
|
2020-11-06 |
2023-06-22 |
Eli Lilly And Company |
Variant adeno-associated virus (aav)capsid polypeptides and gene therapeutics thereof for treatment of hearing loss
|
|
EP4008788A1
(en)
|
2020-12-03 |
2022-06-08 |
Medizinische Hochschule Hannover |
Lentiviral vector technology for inner ear gene therapy
|
|
CN117295529A
(zh)
|
2021-02-19 |
2023-12-26 |
分贝治疗公司 |
使用耳畸蛋白双载体系统治疗感觉神经性听力损失的方法
|
|
CN113337507B
(zh)
|
2021-08-05 |
2021-11-12 |
首都医科大学附属北京友谊医院 |
Otof 1273 (C>T)基因定点突变的耳聋小鼠模型的构建方法及其应用
|